Cargando…

Case report: Structural brain abnormalities in TUBA1A-tubulinopathies: a narrative review

INTRODUCTION: Tubulin genes have been related to severe neurological complications and the term “tubulinopathy” now refers to a heterogeneous group of disorders involving an extensive family of tubulin genes with TUBA1A being the most common. A review was carried out on the complex and severe brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavone, Piero, Striano, Pasquale, Cacciaguerra, Giovanni, Marino, Simona Domenica, Parano, Enrico, Pappalardo, Xena Giada, Falsaperla, Raffaele, Ruggieri, Martino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515619/
https://www.ncbi.nlm.nih.gov/pubmed/37744437
http://dx.doi.org/10.3389/fped.2023.1210272
Descripción
Sumario:INTRODUCTION: Tubulin genes have been related to severe neurological complications and the term “tubulinopathy” now refers to a heterogeneous group of disorders involving an extensive family of tubulin genes with TUBA1A being the most common. A review was carried out on the complex and severe brain abnormalities associated with this genetic anomaly. METHODS: A literature review of the cases of TUBA1A-tubulopathy was performed to investigate the molecular findings linked with cerebral anomalies and to describe the clinical and neuroradiological features related to this genetic disorder. RESULTS: Clinical manifestations of TUBA1A-tubulinopathy patients are heterogeneous and severe ranging from craniofacial dysmorphism, notable developmental delay, and intellectual delay to early-onset seizures, neuroradiologically associated with complex abnormalities. TUBA1A-tubulinopathy may display various and complex cortical and subcortical malformations. DISCUSSION: A range of clinical manifestations related to different cerebral structures involved may be observed in patients with TUBA1A-tubulinopathy. Genotype–phenotype correlations are discussed here. Individuals with cortical and subcortical anomalies should be screened also for pathogenic variants in TUBA1A.